Clinical Trial Update: A Retrospective Study to Evaluate the Safety and Efficacy of a Nucleoside-Sparing Regimen of Darunavir, Ritonavir, and Dolutegravir

View source ↗

Summary

A retrospective study assessing safety and efficacy of a nucleoside-sparing regimen (darunavir/ritonavir/dolutegravir) for HIV-1 infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Darunavir/ritonavir/dolutegravir

Snippet

Sponsor: Southern Illinois Healthcare Foundation | Conditions: HIV-1-infection | Status: COMPLETED | Results posted: 2020-07-07